
Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided…

Asimov provides scientists and manufacturers tools that simplify designing and manufacturing biologic drugs and gene therapies. The company combines mammalian synthetic biology with computer-aided…
Headquarters & focus: Boston-based synthetic biology company building CAD-style platform for biologic, cell, gene, and RNA therapeutic design
Product: Integrated platform of engineered host cell lines, validated genetic parts, and cloud-based design software (CHO Edge, LV Edge, AAV Edge, RNA Edge)
Founding: Founded in 2017 by Alec Nielsen, Christopher Voigt, Douglas Densmore, and Raja Srinivas
Funding: Reported total funding approximately $205M, including a reported $200M round announced Jan 2023
Employees: Approximately 106 employees
Design and manufacturing tooling for next-generation biologics, cell, gene, and RNA therapies.
2017
Biotechnology Research
4700000
Reported seed financing at company launch
200000000
Reported large institutional financing announced Jan 2023
“AME Cloud Ventures, Andreessen Horowitz, CPP Investments, Casdin Capital, DCVC, Fidelity, Horizons Ventures, KdT Ventures, Pillar VC”
| Company |
|---|
Our mission at Asimov is to advance humanity's ability to design living systems, enabling biotechnologies with outsized benefit to society. We're developing a mammalian synthetic biology platform––from cells to software––to enable the design and manufacture of next-generation therapeutics.
We are searching for a Senior Computational Biologist with multi-disciplinary skills in computational biology, machine learning, and applied mathematics to join our team. This role bridges the gap between sequence-level design and systems-level dynamics, focusing on the development and application of sophisticated models that integrate diverse biological data.
The ideal candidate will be adept at building data-driven, mechanistic, and hybrid models to decipher complex biological processes and guide the engineering of therapeutic molecules and systems. You will leverage everything from high-dimensional omics datasets to time-course bioprocess data to create predictive models that drive genetic design and optimize bioprocess development. Join our team to contribute at the cutting-edge of innovation in biology and computational science, shaping the future of therapeutic innovation.
About The Role
About You
We're fueled by a vision to transform biological engineering into a fully-fledged engineering discipline. Should you join our team, you will grow with a constantly evolving organization and push the frontiers of synthetic biology. Company culture is key to Asimov, and ours is a culture of recombination; we believe that our mission can only be achieved by bringing together a diverse team with a mixture of backgrounds and perspectives.
Compensation Range: $150K - $175K
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week